找回密码
 注册

QQ登录

只需一步,快速开始

搜索
查看: 3885|回复: 7

[了解肝移植] 看了篇文章,关于做60岁以上的做肝移植的存活率与年轻人相比的

[复制链接]
发表于 2010-3-18 01:06:58 | 显示全部楼层 |阅读模式 来自: 比利时
原文是英文的,在最下面,大致是讲比较了两组病人,一组是60岁以上,另外一组是18-59岁的,移植的原因都是良性病(丙肝,肝硬化,胆管炎等),最初几年的存活率差不多,但长期来说,5年存活率第一组是52%,第二组是75%;10年的话第一组是35%,第二组是60%。导致第一组死亡的主要原因是恶性肿瘤,第二组的主因是感染并发症。

我有个疑问,既然做移植的病人都是因为良性病做的手术,为什么年长的病人有一部分最后都得了恶性肿瘤。还有就是年轻人很大一部分死因都因为感染,这也太可惜了,问问大家,想这种得恶性肿瘤和感染应该都是可以避免的吧?尤其是后者,大家日常生活中还是要注意这些方面。

Long-Term Results of Liver Transplantation in Patients 60 Years of Age and Older


Background. Advances in perioperative care and immunosuppression have enabled clinicians to broaden the indications for organ transplantation. Advanced age is no longer considered a contraindication to transplantation at most centers. Although short-term studies of elderly liver transplant recipients have demonstrated that the incidence of complications and overall patient survival are similar to those of younger adults, transplant center-specific, long-term data are not available.

Methods. From August of 1984 to September of 1997, 91 patients 60 years of age or older received primary liver transplants at the University of Wisconsin, Madison. This group of patients was compared with a group of younger adults (n=387) ranging in age from 18 to 59 years who received primary liver transplants during the same period. The most common indications for transplantation in both groups were Laennec's cirrhosis, hepatitis C, primary biliary cirrhosis, primary sclerosing cholangitis, and cryptogenic cirrhosis. There was no difference in the preoperative severity of illness between the groups.

Results. The length of hospitalization was the same for both groups, and there were no significant differences in the incidence of rejection, infection (surgical or opportunistic), repeat operation, readmission, or repeat transplantation between the groups. The only significant difference identified between the groups was long-term survival. Five-year patient survival was 52% in the older group and 75% in the younger group (P <0.05). Ten-year patient survival was 35% in the older group and 60% in the younger group (P <0.05). The most common cause of late mortality in elderly liver recipients was malignancy (35.0%), whereas most of the young adult deaths were the result of infectious complications (24.2%).


Conclusion. Although older recipients at this center did as well as younger recipients in the early years after liver transplantation, long-term survival results were not as encouraging.



发表于 2010-3-18 06:14:47 | 显示全部楼层 来自: 山西长治

楼主的英文水平高啊.

正常的老年人也比年轻人更容易得恶性肿瘤. 移植后吃的FK等,都有得恶性肿瘤的副作用.

但至于感染是为什么就不知道了.

发表于 2010-3-18 11:32:03 | 显示全部楼层 来自: 陕西西安
我爸爸就属于良性病,但是之活了2年。他走的原因归结为肝肾不合,FK的副作用。所以我觉得60岁以上做此手术应该觉得值,因为你毕竟多看了几年世界。
发表于 2010-3-18 12:53:41 | 显示全部楼层 来自: 江苏南通
肿瘤感染都是因为免疫抑制剂的原因,免疫力低下了。

但很难去界定,日常,正好最好了。

复查的时候咨询医生骁悉的问题,是否一定是骁悉副作用特别,医生说,FK也一样,都会造成感染什么的。
发表于 2010-3-21 07:14:17 | 显示全部楼层 来自: 重庆
人都要死,活好每一天。
发表于 2010-3-21 09:37:17 | 显示全部楼层 来自: 黑龙江哈尔滨

lz提供的这个资料是不是好多年前的啊

都是84-97年间手术的人的统计呢

那时候手术手法,术后用药跟现在会有差别的

有新点的文献吗?

多提供点吧,多谢了

 楼主| 发表于 2010-3-21 23:13:49 | 显示全部楼层 来自: 比利时
以下是引用丁丁和明明在2010-3-21 14:37:17的发言:

lz提供的这个资料是不是好多年前的啊

都是84-97年间手术的人的统计呢

那时候手术手法,术后用药跟现在会有差别的

有新点的文献吗?

多提供点吧,多谢了


我google来的,结果肯定是滞后的:要统计10年存活率至少得观察10年啊,也就是说这数据也就发表了3年而已。

当然现在的医学水平肯定更高,期待日后越来越多的好消息
发表于 2010-3-22 06:20:56 | 显示全部楼层 来自: 辽宁沈阳

感染和肿瘤都跟免疫抑制剂有关系,所以建议大家多多锻炼,增强身体抵抗疾病的能力!

您需要登录后才可以回帖 登录 | 注册

本版积分规则

小黑屋|手机版|移友网社区 ( 京ICP备18051075号-2 )

GMT+8, 2026-7-17 07:51 , Processed in 0.022668 second(s), 16 queries .

Powered by Discuz! X3.5

© 2001-2026 Discuz! Team.

快速回复 返回顶部 返回列表